all report title image
  • Published In : Apr 2024
  • Code : CMI6883
  • Pages : 175
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

The global liposome drug delivery market is estimated to be valued at USD 5,482.2 Mn in 2024 and is expected to exhibit a CAGR of 8.9% during the forecast period (2024-2031). Liposome drug delivery is a promising approach for targeted drug delivery and release. Liposomes are artificially prepared vesicles made up of lipid bilayers similar to cell membranes that can encapsulate both hydrophobic and hydrophilic drugs within their aqueous core and lipid membranes respectively. This enables liposomes to serve as nanocarriers for the delivery of various therapeutic agents to target sites, enhancing their efficacy and bioavailability while reducing toxicity to healthy tissues. Recent advancements in liposomal formulations have improved drug loading capacity, stability in blood circulation as well as active or passive targeting capabilities, making them potential candidates for delivery of anti-cancer drugs, vaccines, gene therapies, and others.

Market Dynamics:

The global liposome drug delivery market is driven by the rising prevalence of cancer and other chronic diseases, increasing demand for targeted drug delivery systems, and growing R&D investments from key players in the nanomedicine and biopharma sectors. However, high costs associated with drug development and regulatory approvals continue to restrain broader market adoption. Growing interest in personalized medicine and nanotechnology-based formulations present significant opportunities for liposome drugs manufacturers. Strategic collaborations between drug makers and liposome technology providers are helping expand therapeutic applications into areas such as infectious diseases, pain management, and autoimmune disorders.

Key Features of the Study:

  • This report provides an in-depth analysis of the global liposome drug delivery market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global liposome drug delivery market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Gilead Sciences, Inc., Luye Pharma Group, Ipsen Biopharmaceuticals, Inc., Pacira Pharmaceuticals, Inc., Acuitas Therapeutics, LIPOSOMA B.V., Takeda Pharmaceutical Company Limited, Taiwan Liposome Company, Ltd., Endo International, and Jazz Pharmaceuticals plc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global liposome drug delivery market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposome drug delivery market

Detailed Segmentation-

  • Product:
    • Liposomal Paclitaxel
    • Liposomal Doxorubicin
    • Liposomal Amphotericin B
    • Others
  • Technology:
    • Stealth Liposome Technology
    • Non-PEGylated Liposome Technology
    • DepoFoam Liposome Technology
  • Indication:
    • Fungal Diseases
    • Pain Management
    • Cancer Therapeutics
    • Others
  • End User:
    • Hospitals
    • Clinics
    • Research Laboratories
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Gilead Sciences, Inc.
    • Luye Pharma Group
    • Ipsen Biopharmaceuticals, Inc. 
    • Pacira Pharmaceuticals, Inc.
    • Acuitas Therapeutics
    • LIPOSOMA B.V.
    • Takeda Pharmaceutical Company Limited
    • Taiwan Liposome Company, Ltd.
    • Endo International
    • Jazz Pharmaceuticals plc

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product
      • Market Snapshot, By Technology
      • Market Snapshot, By Indication
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Regulatory Scenario
    • Product Launches/Approvals
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Liposome Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 impact on the market
  5. Global Liposome Drug Delivery Market, By Product, 2019 – 2031, (USD Mn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Liposomal Paclitaxel
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Liposomal Doxorubicin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Liposomal Amphotericin B
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Nasal Endoscopes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
  6. Global Liposome Drug Delivery Market, By Technology, 2019 – 2031, (USD Mn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Stealth Liposome Technology
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Non-PEGylated Liposome Technology
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • DepoFoam Liposome Technology
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
  7. Global Liposome Drug Delivery Market, By Indication, 2019 – 2031, (USD Mn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Fungal Diseases
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Pain Management
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Cancer Therapeutics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
  8. Global Liposome Drug Delivery Market, By End User, 2019 – 2031, (USD Mn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Research Laboratories
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
  9. Global Liposome Drug Delivery Market, By Region, 2019 – 2031, (USD Mn)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Mn)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Company Profiles
      • Gilead Sciences, Inc. *
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Luye Pharma Group
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Ipsen Biopharmaceuticals, Inc. 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pacira Pharmaceuticals, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Acuitas Therapeutics
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • LIPOSOMA B.V.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Takeda Pharmaceutical Company Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Taiwan Liposome Company, Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Endo International
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Jazz Pharmaceuticals plc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  11. Analyst View
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 35 figures on “Liposome Drug Delivery Market” - Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo